| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015998603 |
| P356 | DOI | 10.1038/JHG.2012.57 |
| P932 | PMC publication ID | 3407369 |
| P698 | PubMed publication ID | 22622361 |
| P5875 | ResearchGate publication ID | 225058406 |
| P50 | author | Elena B Volokhina | Q42425280 |
| Matthew C Pickering | Q55692581 | ||
| P2093 | author name string | Lambert P van den Heuvel | |
| Dineke Westra | |||
| Katherine A Vernon | |||
| Nicole C A J van de Kar | |||
| P2860 | cites work | Human factor H-related protein 5 (FHR-5). A new complement-associated protein | Q24290461 |
| Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis | Q24615589 | ||
| Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) | Q24655016 | ||
| Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome | Q24685473 | ||
| Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS) | Q28271502 | ||
| Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome | Q28283865 | ||
| Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease | Q33357336 | ||
| Familial haemolytic uraemic syndrome and an MCP mutation | Q33357579 | ||
| Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome | Q33361085 | ||
| Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. | Q33364613 | ||
| Genetic analysis of the complement factor H related 5 gene in haemolytic uraemic syndrome | Q33372755 | ||
| Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome | Q33373674 | ||
| Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency | Q33377384 | ||
| Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome | Q33381182 | ||
| Complement factor H related proteins in immune diseases | Q33384194 | ||
| Thrombomodulin mutations in atypical hemolytic-uremic syndrome | Q33385474 | ||
| Atypical hemolytic-uremic syndrome | Q33386736 | ||
| Escherichia coliO157:H7 and the Hemolytic–Uremic Syndrome | Q33488736 | ||
| The pathogenesis and treatment of hemolytic uremic syndrome. | Q33502711 | ||
| Factor H-related protein-5: a novel component of human glomerular immune deposits | Q34107748 | ||
| Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. | Q34416754 | ||
| Regulating complement in the kidney: insights from CFHR5 nephropathy | Q35532337 | ||
| Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration. | Q37154954 | ||
| Eculizumab for Atypical Hemolytic–Uremic Syndrome | Q57636966 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atypical hemolytic uremic syndrome | Q17165460 |
| P304 | page(s) | 459-464 | |
| P577 | publication date | 2012-05-24 | |
| P1433 | published in | Journal of Human Genetics | Q6295302 |
| P1476 | title | Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene | |
| P478 | volume | 57 |
| Q33424946 | Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort |
| Q56591965 | Atypical hemolytic uremic syndrome |
| Q38824060 | Atypical hemolytic uremic syndrome: a clinical conundrum |
| Q38057737 | C3 glomerulonephritis and CFHR5 nephropathy |
| Q33432063 | Complement and the kidney in the setting of Shiga-toxin hemolytic uremic syndrome, organ transplantation, and C3 glomerulonephritis |
| Q38066214 | Complement diagnostics: concepts, indications, and practical guidelines |
| Q26851489 | Complement factor H related proteins (CFHRs) |
| Q34508359 | Exploring the genetic basis of early-onset chronic kidney disease |
| Q47111288 | Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma |
| Q40161972 | Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation |
| Q33402007 | Increasing evidence that genetic variation in complement factor H related 5 (CFHR5) causes disease: a commentary on 'Atypical haemolytic uremic syndrome and genetic aberrations in the complement factor-H-related 5 gene'. |
| Q58566667 | Interpretation of Serological Complement Biomarkers in Disease |
| Q57193128 | Panel sequencing distinguishes monogenic forms of nephritis from nephrosis in children |
| Q91950321 | Personalized medicine in chronic kidney disease by detection of monogenic mutations |
| Q40974164 | Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy |
| Q58803464 | Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children |
| Q92242808 | Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers |
| Q33411571 | Renal function in normal and disordered pregnancy |
| Q37032691 | The Genetics of Ultra-Rare Renal Disease |
| Q90562836 | Thrombotic microangiopathy in a patient with eosinophilic granulomatosis with polyangiitis: case-based review |
Search more.